RhumbLine Advisers’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

RhumbLine Advisers’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-29,681	Closed	-$1.22M	–	3039
2015 Q2	$1.22M	Sell	29,681 -1,765	-6%	-$63.3K	﹤0.01%	1735
2015 Q1	$1.11M	Buy	31,446 +3,220	+11%	+$109K	﹤0.01%	1793
2014 Q4	$907K	Sell	28,226 -325	-1%	-$9.4K	﹤0.01%	1877
2014 Q3	$801K	Sell	28,551 -80	-0.3%	-$2.44K	﹤0.01%	1909
2014 Q2	$865K	Buy	28,631 +48	+0.2%	+$1.32K	﹤0.01%	1921
2014 Q1	$791K	Sell	28,583 -1,920	-6%	-$50.2K	﹤0.01%	1950
2013 Q4	$779K	Sell	30,503 -300	-1%	-$9.24K	﹤0.01%	1980
2013 Q3	$920K	Sell	30,803 -429	-1%	-$11.9K	﹤0.01%	1834
2013 Q2	$898K	Buy	+31,232	New	+$861K	﹤0.01%	1835

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

RhumbLine Advisers's BRLI Position: Q3 2015 in Review

RhumbLine Advisers sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 29,681 shares — an estimated $1.22M sold.

RhumbLine Advisers first reported a position in BRLI in Q2 2013 and held it in 9 quarters. The position peaked at $1.22M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

RhumbLine Advisers reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
RhumbLine Advisers sold 29,681 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $1.22M.
RhumbLine Advisers first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 9 quarters.
RhumbLine Advisers's BIO-REFERENCE LABS INC-NEW- position peaked at $1.22M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on RhumbLine Advisers's 13F filing for Q3 2015, filed 4 Nov 2015.